comparemela.com

Anitaw Asgar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

TCT23 Late-breakers: Full Schedule Announced

Late-breaking trials will be presented during the main sessions and highlighted during press conferences scheduled for Oct. 24, 25 and 26

United statesSan franciscoSuzannev arnoldDavide kandzariRobertl smithDavidh adamsAmitn voraSusheelk kodaliJoanna chikweSuzannej baronFiras zahrAnitaw asgarTobias kochMirvat alasnagRoberto bonowRobertw yeh

PASCAL for MV Repair Noninferior to MitraClip: Pivotal CLASP IID

A newly FDA-approved transcatheter mitral valve repair system and another one widely used for years were similarly safe and effective in an interim analysis of a randomized trial.

United statesNew hampshireNew jerseyVinodh thouraniAnitaw asgarKonstantinos koulogiannisEdwards lifesciencesMichael youngUniversity of virginia health system hospitalPiedmont heart instituteMorristown medical centerDrug administrationBoston scientificHitchcock medical centerW gore associatesEuropean union on

In Cardiogenic Shock, Edge-to-Edge Mitral Valve Repair Improves Outcome

Transcatheter edge-to-edge repairs were associated with lower mortality and hospitalization in an analysis of a large, international registry.

United statesNew havenYale universityAnitaw asgarMohamada alkhouliAlexandraj lanskyMontreal heart instituteVascular research programSociety of thoracic surgeonsCardiovascular research foundationMayo clinicAmerican collegeCardiology transcatheter valve therapy registryCardiovascular researchAmerican heart journalThoracic surgeons

Mitral Valve Repair Devices Go Head-to-Head, and the Top Spot Belongs to

CLASP IID trial crowns no winner but champions expanding choices

United statesAnitaw asgarFedericom aschJanea leopoldEdwards lifesciencesBernard prendergastMontreal heart instituteYork heart associationMedstar healthAmerican college of cardiologyUniversity of virginia health system in charlottesvilleCardiovascular research foundationVirginia health systemTranscatheter cardiovascular therapeuticsCardiovascular researchPascal precision

vimarsana © 2020. All Rights Reserved.